2002
DOI: 10.1006/jsre.2002.6385
|View full text |Cite
|
Sign up to set email alerts
|

Ischemia/Reperfusion Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
163
0
9

Year Published

2003
2003
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 203 publications
(174 citation statements)
references
References 128 publications
2
163
0
9
Order By: Relevance
“…Normally, living organisms are protected from the dangerous effects of O 2 À by SOD, which converts O 2 À into H 2 O 2 [68][69][70] . Whereas, during reperfusion of ischemic tissues, these natural defences may not be overcome and H 2 O 2 is converted into OH , this transformation has the capacity to damage a wide range of biomolecules species containing amino acids, membrane proteins and nucleic acids [71][72][73] . CAT is an oxidoreductase that catalyzes the conversion of H 2 O 2 to H 2 O and O 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Normally, living organisms are protected from the dangerous effects of O 2 À by SOD, which converts O 2 À into H 2 O 2 [68][69][70] . Whereas, during reperfusion of ischemic tissues, these natural defences may not be overcome and H 2 O 2 is converted into OH , this transformation has the capacity to damage a wide range of biomolecules species containing amino acids, membrane proteins and nucleic acids [71][72][73] . CAT is an oxidoreductase that catalyzes the conversion of H 2 O 2 to H 2 O and O 2 .…”
Section: Resultsmentioning
confidence: 99%
“…However, during oxidative stress conditions, the balance between ROS and antioxidants shifts toward the former, resulting in liver damage [51].…”
Section: Ischemia/reperfusion Liver Injury and Free Radicalsmentioning
confidence: 99%
“…4 The pathophysiology of ischemiareperfusion injury is complex, with activation of neutrophils and release of reactive oxygen species and other inflammatory mediators. 5 Since it was demonstrated that specific complement inhibition with soluble complement receptor 1 (sCR1) markedly attenuated the tissue damage in experimental myocardial infarction, 6 a large body of evidence has accumulated demonstrating an essential role for complement in ischemia-reperfusion injury. This is supported by studies showing a therapeutic benefit of complement blockade in various ischemia-reperfusion injury models, as reviewed elsewhere.…”
mentioning
confidence: 99%